BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27899525)

  • 21. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
    Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MAVS-mediated host cell defense is inhibited by Borna disease virus.
    Li Y; Song W; Wu J; Zhang Q; He J; Li A; Qian J; Zhai A; Hu Y; Kao W; Wei L; Zhang F; Xu D
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1546-55. PubMed ID: 23702035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmacytoid Dendritic Cells Mediate Control of Ross River Virus Infection via a Type I Interferon-Dependent, MAVS-Independent Mechanism.
    Haist KC; Carpentier KS; Davenport BJ; Morrison TE
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3.
    Sen A; Pruijssers AJ; Dermody TS; García-Sastre A; Greenberg HB
    J Virol; 2011 Apr; 85(8):3717-32. PubMed ID: 21307186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spring Viremia of Carp Virus N Protein Suppresses Fish IFNφ1 Production by Targeting the Mitochondrial Antiviral Signaling Protein.
    Lu LF; Li S; Lu XB; LaPatra SE; Zhang N; Zhang XJ; Chen DD; Nie P; Zhang YA
    J Immunol; 2016 May; 196(9):3744-53. PubMed ID: 26994222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium.
    Broquet AH; Hirata Y; McAllister CS; Kagnoff MF
    J Immunol; 2011 Feb; 186(3):1618-26. PubMed ID: 21187438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
    He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
    J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of SUMO3-conjugated chains of MAVS induced by poly(dA:dT), a ligand of RIG-I, enhances the aggregation of MAVS that drives the secretion of interferon-β in human keratinocytes.
    Choi GW; Lee Y; Yun M; Kang J; Lee SB
    Biochem Biophys Res Commun; 2020 Feb; 522(4):939-944. PubMed ID: 31806367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential MAVS and MyD88/TRIF signaling triggers anti-viral responses of tick-borne encephalitis virus-infected murine astrocytes.
    Ghita L; Breitkopf V; Mulenge F; Pavlou A; Gern OL; Durán V; Prajeeth CK; Kohls M; Jung K; Stangel M; Steffen I; Kalinke U
    J Neurosci Res; 2021 Oct; 99(10):2478-2492. PubMed ID: 34296786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOX9 negatively regulates the RLR antiviral signaling by targeting MAVS.
    Jiang X; Xu LG
    Virus Genes; 2022 Apr; 58(2):122-132. PubMed ID: 35103914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
    Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
    J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses.
    Wang B; Xi X; Lei X; Zhang X; Cui S; Wang J; Jin Q; Zhao Z
    PLoS Pathog; 2013 Mar; 9(3):e1003231. PubMed ID: 23555247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.
    Gergely P; Niland B; Gonchoroff N; Pullmann R; Phillips PE; Perl A
    J Immunol; 2002 Jul; 169(2):1092-101. PubMed ID: 12097418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIRT5 impairs aggregation and activation of the signaling adaptor MAVS through catalyzing lysine desuccinylation.
    Liu X; Zhu C; Zha H; Tang J; Rong F; Chen X; Fan S; Xu C; Du J; Zhu J; Wang J; Ouyang G; Yu G; Cai X; Chen Z; Xiao W
    EMBO J; 2020 Jun; 39(11):e103285. PubMed ID: 32301534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of type I interferon responses by mitochondria-derived reactive oxygen species in plasmacytoid dendritic cells.
    Agod Z; Fekete T; Budai MM; Varga A; Szabo A; Moon H; Boldogh I; Biro T; Lanyi A; Bacsi A; Pazmandi K
    Redox Biol; 2017 Oct; 13():633-645. PubMed ID: 28818792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T Cell Homeostatic Proliferation Promotes a Redox State That Drives Metabolic and Epigenetic Upregulation of Inflammatory Pathways in Lupus.
    Budd RC; Scharer CD; Barrantes-Reynolds R; Legunn S; Fortner KA
    Antioxid Redox Signal; 2022 Mar; 36(7-9):410-422. PubMed ID: 34328790
    [No Abstract]   [Full Text] [Related]  

  • 37. Low Production of Reactive Oxygen Species Drives Systemic Lupus Erythematosus.
    Urbonaviciute V; Luo H; Sjöwall C; Bengtsson A; Holmdahl R
    Trends Mol Med; 2019 Oct; 25(10):826-835. PubMed ID: 31303528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of MAVS regulation at the mitochondrial membrane.
    Jacobs JL; Coyne CB
    J Mol Biol; 2013 Dec; 425(24):5009-19. PubMed ID: 24120683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein.
    Wei C; Ni C; Song T; Liu Y; Yang X; Zheng Z; Jia Y; Yuan Y; Guan K; Xu Y; Cheng X; Zhang Y; Yang X; Wang Y; Wen C; Wu Q; Shi W; Zhong H
    J Immunol; 2010 Jul; 185(2):1158-68. PubMed ID: 20554965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling.
    Shi Z; Zhang Z; Zhang Z; Wang Y; Li C; Wang X; He F; Sun L; Jiao S; Shi W; Zhou Z
    J Biol Chem; 2015 Oct; 290(44):26811-20. PubMed ID: 26385923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.